Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting
Provided By GlobeNewswire
Last update: Jun 30, 2025
Data show that simufilam reduced seizure activity in a preclinical mouse model
Presentation also highlights favorable human safety data from 1,929 patient Phase 3 program
Read more at globenewswire.com
